Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Blog 勘测全球范围监管申请建模与模拟的现状 Analogous to how a geologist surveys the “lay of the land” to determine if oil…Certara2018 年 2 月 16 日
Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach Publication Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach Certara2017 年 9 月 15 日
Drug Asset Evaluation: Increasing “Probability of Success” of a Deal White Paper 药物资产评估:提高交易的 "成功概率” Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…Certara2017 年 8 月 24 日
Investigational Drug Gap Analysis Brochure 研究用药物差距分析 As the process of drug development has increased in cost and complexity, Certara has developed…Certara2017 年 8 月 14 日
Clinical Pharmacology—The Quarterback of Drug Development Press Coverage 临床药理学 – 药物开发的关键 Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…Certara2017 年 8 月 14 日
A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor Publication A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor Certara2017 年 1 月 10 日
Lessons Learned: Dose Selection of Small Molecule-targeted Oncology Drugs Publication Lessons Learned: Dose Selection of Small Molecule-targeted Oncology Drugs Certara2016 年 6 月 1 日